ERBB2 and breast cancer: In fact, this is in agreement with previous studies which documented that primary BC had more missense mutations in luminal/ER+ and epidermal growth receptor 2 positive (HER2+) subtypes while in triple negative breast cancers (TNBCs), nonsense, frameshift, and complex mutations were more common variations [8].